Assessing hERG Channel Inhibition Using PatchXpress

Journal of Laboratory Automation

Volumn 10, Issue 4, 2005, Pages 225-230

  Ly, Justin Q ^a   Shyy, Gordon ^a   Misner, Dinah L ^a  

^a ROCHE BIOSCIENCE   (United States)

Author keywords

acquired long QT; automation; channel; hERG potassium; syndrome; throughput; voltage clamp

Indexed keywords

AUTOMATION; CELL CULTURE; CELLS; ENZYMES; GLASS; POLYSTYRENES; POTASSIUM;

ACQUIRED LONG QT SYNDROME; HERG POTASSIUM CHANNEL; HUMAN ETHER-A-GO-GO RELATED GENE (HERG); VOLTAGE CLAMP;

GENES;

AMIODARONE; ASTEMIZOLE; BEPRIDIL; DOFETILIDE; DULOXETINE; GLASS; HALOPERIDOL; OLANZAPINE; PAROXETINE; POLYSTYRENE; POTASSIUM CHANNEL HERG; POTASSIUM ION; QUINIDINE; TERFENADINE; TRYPSIN; VERAPAMIL;

ANIMAL CELL; ARTICLE; AUTOMATION; CELL CULTURE; CELL ISOLATION; CELL LINE; CHANNEL GATING; CONTROLLED STUDY; INHIBITION KINETICS; INTERMETHOD COMPARISON; INTRACELLULAR RECORDING; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT;

EID: 23844548574     PISSN: 22110682     EISSN: 15402452     Source Type: Journal    
DOI: 10.1016/j.jala.2005.05.002     Document Type: Article

References (7)

1. Westenskow P. Splawski I. Timothy K. W. Keating M. T. Sanguinetti C. Circulation 2004, 109, 1834–1841.
2. Taglialatela M. Cataldo P. Pannaccione A. Giorgio G. Annunziato L. Biochem. Pharm. 1998, 55, 1741–1746.
3. Yost S. C. Anesthesiology 1999, 90, 1186–1203.
4. Wood C. Williams C. Waldron G. Drug Disc. Today 2004, 9, 434–441.
5. Wang X. Li M., Assay Drug Dev. Technol. 2003, 1, 695–708.
6. Xu J. Guia A. Rothwarf D. Huang M. Sithiphong K. Ouang J. Tao G. Wang X. Wu L. Assay Drug Dev. Technol. 2003, 1, 675–684.
7. Hamill O. P. Marty A. Neher E. Sakmann B. Sigworth F. J. Pfluegers Arch. 1981, 391, 85–100.